Left motor cortex rTMS effects on brain connectivity
Official title: Effects of Left Primary Motor Cortex rTMS on Cortical Connectivity Assessed With TMS-EEG Across Left M1, Right M1, Premotor, and Occipital Cortices
Run by Aalborg University · NCT07580989 · Data updated 2026-11-12
This will test whether one session of rTMS to the left motor cortex changes EEG-measured brain connectivity in healthy adult volunteers.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Aalborg University Academic / other |
| Locations | 1 site (Gistrup) |
| Status | Recruiting |
| Started | May 1, 2026 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2027 |
| Registry record updated | May 14, 2026 |
| Trial ID | NCT07580989 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are healthy adults who speak English, can consent and cooperate with procedures, and have no history of neurological, psychiatric, chronic pain, or contraindications to rTMS.
✕Probably not a fit
People with current or past neurological or psychiatric disorders, chronic or acute pain, substance use, or contraindications to TMS (for example epilepsy or metal in the head/jaw) are not likely to benefit and are excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Healthy volunteers will receive a single session of repetitive transcranial magnetic stimulation (rTMS) over the left primary motor cortex with TMS-EEG recordings taken before and after stimulation. TMS pulses will be applied to four cortical targets—the left and right primary motor cortices, left premotor cortex, and right occipital cortex—to record TMS-evoked potentials (TEPs) that reflect cortical reactivity and connectivity. Pre- versus post-rTMS comparisons of TEPs will be used to map changes in network responses and determine whether one rTMS session alters large-scale cortical interactions. Participants will be screened for safety and excluded for neurological, psychiatric, chronic pain, or substance-use contraindications.
Why it matters
Potential benefit: If successful, the results could clarify how rTMS changes brain network activity and help refine stimulation targets or protocols for treating neurological and psychiatric conditions.
How similar studies have gone: Previous TMS-EEG and rTMS studies have demonstrated modulation of cortical responses after stimulation, but findings are variable and the mechanisms of network-level changes remain incompletely established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Healthy men and women * Speak and understand English Exclusion Criteria: * Drug addiction defined as the use of cannabis, opioids or other drugs * Previous neurologic, musculoskeletal or mental illnesses * Lack of ability to cooperate * History of chronic pain or current acute pain * Contraindications to rTMS application (history of epilepsy, metal in the head or jaw etc.). * Failure to pass the "TASS questionnaire" (TASS = Transcranial Magnetic Stimulation Adult Safety Screen)
Where it's running
-
Aalborg University
Gistrup, Denmark Recruiting
Study contacts
- Study coordinator: Enrico De Martino
- Email: edm@hst.aau.dk
- Phone: +4591811183
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ear vagus‑nerve stimulation for capsaicin-induced and pressure pain
This test will see if brief burst electrical stimulation of the ear's vagus nerve reduces capsaicin-induced skin pain and pressure pain in healthy adults.
-
Personalized rTMS for chronic pain using each person's TMS-EEG brain signals
This trial will try personalized repetitive transcranial magnetic stimulation (rTMS), picking the brain target from each person's TMS-EEG patterns, to see if it reduces chronic pain in adults who have had pain most days for at least three months.
-
Exploring How Contagious Itch Works on the Skin
This study tests how itch spreads when histamine, cowhage, or a placebo are applied to the forearms to see how people feel itch and pain.
-
Placebo effects on histamine and cowhage-induced itch
This one-time, 1½-hour session will test whether applying a harmless cream reduces histamine- and cowhage-induced itch in healthy adults aged 18–60.
-
Personalized magnetic brain stimulation for chronic pain
This trial will try personalized rTMS guided by each person's EEG to see if it reduces pain in adults with chronic pain.
-
Delgocitinib, lidocaine, or both for itch relief in healthy adults
This study tests whether delgocitinib, lidocaine, or their combination can reduce experimentally induced itching in healthy adults aged 18-60.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.